High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: The role of esophagectomy in the era of endoscopic eradication therapy

Current Opinion in Gastroenterology

Volumn 28, Issue 4, 2012, Pages 362-369

  Luna, Renato A ^a   Gilbert, Erin ^a   Hunter, John G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Barrett's esophagus; early esophageal adenocarcinoma; endoscopic ablation; endoscopic mucosal resection; esophagectomy

Indexed keywords

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER STAGING; CARCINOMA IN SITU; CLINICAL ASSESSMENT; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; ESOPHAGUS HEMORRHAGE; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STENOSIS; ESOPHAGUS STRICTURE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MORTALITY; MULTICENTER STUDY (TOPIC); PHOTODYNAMIC THERAPY; PREVALENCE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR RECURRENCE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CATHETER ABLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; HUMANS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS;

EID: 84862281895     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328353e346     Document Type: Review

References (67)

1. Gilbert EW, Luna RA, Harrison VL, Hunter JG. Barrett's esophagus: A review of the literature. J Gastrointest Surg 2011; 15:708-718.
2. Edge SB, Byrd DR, Compton CC, et al., editors. AJCC Cancer, Staging Manual. 7th ed. New York: Springer; 2010.
3. Rice TW, Blackstone EH, Rybicki LA, et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg 2003; 125:1103-1113.
4. Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: Asophagus and esophagogastric junction. Ann Surg Oncol 2010; 17:1721-1724.
5. Zemler B, May A, Ell C, Stolte M. Early Barrett's carcinoma: The depth of infiltration of the tumor correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion. Virchows Arch 2010; 456:609-614.
6. Shimada H, Nabeya Y, Matsubara H, et al. Prediction of lymph node status in patients with superficial esophageal carcinoma: Analysis of 160 surgically resected cancers. Am J Surg 2006; 191:250-254.
7. Isono K. Guidelines for clinical and pathological studies on carcinoma of the esophagus, ninth edition: Preface, general principals, part I. Esophagus 2004; 1:61-88.
8. Rice TW, Blackstone EH, Goldblum JR, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001; 122:1077-1090.
9. Liu L, Hofstetter WL, Rashid A, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive [T1] esophageal adenocarcinoma. Am J Surg Pathol 2005; 29:1079-1085.
10. Cen P, Hofstetter WL, Correa AM, et al. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 2008; 112: 1020-1027.
11. Altorki NK, Lee PC, Liss Y, et al. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: Implications for endoscopic treatment. Ann Surg 2008; 247:434-439.
12. Sepesi B, Watson TJ, Zhou D, et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg 2010; 210:418-427.
13. Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005; 446:497-504.
14. Ancona E, Rampado S, Cassaro M, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008; 15:3278-3288.
15. Barbour AP, Jones M, Brown I, et al. Risk stratification for early esophageal adenocarcinoma: Analysis of lymphatic spread and prognostic factors. Ann Surg Oncol 2010; 17:2494-2502.
16. Leers JM, DeMeester SR, Oezcelik A, et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg 2011; 253:271-278.
17. Holscher AH, Bollschweiler E, Schroder W, et al. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg 2011; 254:802-807; discussion 807-808.
18. Manner H, May A, Pech O, et al. Early Barrett's carcinoma with 'low-risk' submucosal invasion: Long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008; 103:2589-2597.
19. Alvarez Herrero L, Pouw RE, Van Vilsteren FG, et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: Study based on endoscopic resection specimens. Endoscopy 2010; 42:1030-1036.
20. Moriya H, Ohbu M, Kobayashi N, et al. Lymphatic tumor emboli detected by D2-40 immunostaining can more accurately predict lymph-node metastasis. World J Surg 2011; 35:2031-2037.
21. Pellegrini CA, Pohl D. High-grade dysplasia in Barrett's esophagus: Surveillance or operation? J Gastrointest Surg 2000; 4:131-134.
22. Konda VJ, Ross AS, Ferguson MK, et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol 2008; 6:159-164.
23. Konda VJ, Ferguson MK. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? World J Gastroenterol 2010; 16:3786-3792.
24. Puli SR, Reddy JB, Bechtold ML, et al. Accuracy of endoscopic ultrasound in the diagnosis of distal and celiac axis lymph node metastasis in esophageal cancer: A meta-Analysis and systematic review. Dig Dis Sci 2008; 53:2405-2414.
25. Pech O, May A, Gunter E, et al. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. Am J Gastroenterol 2006; 101:2223-2229.
26. Pech O, Gunter E, Dusemund F, et al. Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer: Results from a referral center for early esophageal cancer. Endoscopy 2010; 42:456-461.
27. Young PE, Gentry AB, Acosta RD, et al. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol 2010; 8:1037-1041.
28. Crabtree TD, Yacoub WN, Puri V, et al. Endoscopic ultrasound for early stage esophageal adenocarcinoma: Implications for staging and survival. Ann Thorac Surg 2011; 91:1509-1515; discussion 1515-1516.
29. Yanai H, Yoshida T, Harada T, et al. Endoscopic ultrasonography of superficial esophageal cancers using a thin ultrasound probe system equipped with switchable radial and linear scanning modes. Gastrointest Endosc 1996; 44:578-582.
30. Moss A, Bourke MJ, Hourigan LF, et al. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: An essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol 2010; 105:1276-1283.
31. Pouw RE, Heldoorn N, Herrero LA, et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc 2011; 73:662-668.
32. Lewis JJ, Rubenstein JH, Singal AG, et al. Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus. Gastrointest Endosc 2011; 74:753-760.
33. Narahara H, Iishi H, Tatsuta M, et al. Effectiveness of endoscopic mucosal resection with submucosal saline injection technique for superficial squamous carcinomas of the esophagus. Gastrointest Endosc 2000; 52:730-734.
34. Cao Y, Liao C, Tan A, et al. Meta-Analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009; 41:751-757.
35. Korst RJ, Santana-Joseph S, Rutledge JR, et al. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: A single-center, phase II clinical trial. J Thorac Cardiovasc Surg 2011; 142:1168-1173.
36. Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with highgrade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008; 57:1200-1206.
37. Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas [Barrett's cancer]. Gastrointest Endosc 2007; 65:3-10.
38. Ganz RA, Overholt BF, Sharma VK, et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: A U.S. Multicenter Registry. Gastrointest Endosc 2008; 68:35-40.
39. Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett's esophagus: A multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008; 68:867-876.
40. Shaheen NJ, Frantz DJ. When to consider endoscopic ablation therapy for Barrett's esophagus. Curr Opin Gastroenterol 2010; 26:361-366.
41. Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011; 141: 460-468.
42. Sharma VK, Jae Kim H, Das A, et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 2009; 104:310-317.
43. Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010; 8:23-29.
44. Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: Initial results and lessons learned. Surg Endosc 2009; 23:2175-2180.
45. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009; 360:2277-2288.
46. Vassiliou MC, von Renteln D, Wiener DC, et al. Treatment of ultralongsegment Barrett's using focal and balloon-based radiofrequency ablation. Surg Endosc 2010; 24:786-791.
47. Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008; 40:370-379.
48. Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus 2007; 20:516-522.
49. Roorda AK, Triadafilopoulos G. Circumferential and focal radiofrequency ablation for the treatment of Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2008; 2:627-634.
50. Connors RC, Reuben BC, Neumayer LA, Bull DA. Comparing outcomes after transthoracic and transhiatal esophagectomy: A 5-year prospective cohort of 17,395 patients. J Am Coll Surg 2007; 205:735-740.
51. Chang AC, Ji H, Birkmeyer NJ, et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008; 85:424-429.
52. Hulscher JB, Van Sandick JW, De Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347:1662-1669.
53. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: Five-year survival of a randomized clinical trial. Ann Surg 2007; 246:992-1000; 1000-1001.
54. Reed MF, Tolis G,Jr, Edil BH, et al. Surgical treatment of esophageal highgrade dysplasia. Ann Thorac Surg 2005; 79:1110-1115; 1110-1115.
55. Pennathur A, Farkas A, Krasinskas AM, et al. Esophagectomy for T1 esophageal cancer: Outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg 2009; 87:1048-1054; discussion 1054-1055.
56. Saha AK, Sutton CD, Sue-Ling H, et al. Comparison of oncological outcomes after laparoscopic transhiatal and open esophagectomy for T1 esophageal adenocarcinoma. Surg Endosc 2009; 23:119-124.
57. Ikeguchi M, Maeta M, Kaibara N. Limited operation for patients with T1 esophageal cancer. Langenbecks Arch Surg 2000; 385:454-458.
58. Grotenhuis BA, Van Heijl M, Zehetner J, et al. Surgical management of submucosal esophageal cancer: Axtended or regional lymphadenectomy? Ann Surg 2010; 252:823-830.
59. DePaula AL, Hashiba K, Ferreira EA, et al. Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc 1995; 5:1-5.
60. Swanstrom LL, Hansen P. Laparoscopic total esophagectomy. Arch Surg 1997; 132:943-947; 947-949.
61. Jobe BA, Kim CY, Minjarez RC, et al. Simplifying minimally invasive transhiatal esophagectomy with the inversion approach: Lessons learned from the first 20 cases. Arch Surg 2006; 141:857-865; discussion 865-866.
62. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: Outcomes in 222 patients. Ann Surg 2003; 238:486-494; discussion 494-495.
63. Perry KA, Enestvedt CK, Pham T, et al. Comparison of laparoscopic inversion esophagectomy and open transhiatal esophagectomy for high-grade dysplasia and stage I esophageal adenocarcinoma. Arch Surg 2009; 144:679-684.
64. Verhage RJ, Hazebroek EJ, Boone J, Van Hillegersberg R. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: A systematic review of the literature. Minerva Chir 2009; 64:135-146.
65. Perry KA, Enestvedt CK, Diggs BS, et al. Perioperative outcomes of laparoscopic transhiatal inversion esophagectomy compare favorably with those of combined thoracoscopic-laparoscopic esophagectomy. Surg Endosc 2009; 23:2147-2154.
66. Das A, Singh V, Fleischer DE, Sharma VK. A comparison of endoscopic treatment and surgery in early esophageal cancer: An analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008; 103:1340-1345.
67. Kinjo Y, Kurita N, Nakamura F, et al. Effectiveness of combined thoracoscopiclaparoscopic esophagectomy: Comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc 2012; 26:381-390.